The Gaudium IVF IPO GMP is gaining strong attention in the primary market as investors look for emerging healthcare and fertility service companies. With a total issue size of ₹165 Cr and a book-building structure, this IPO has attracted interest from both retail and HNI investors. In this detailed guide, we cover Gaudium IVF IPO GMP, price band, IPO dates, review, subscription status, and allotment details — everything you need to know before applying.
If you are tracking the Gaudium IVF IPO GMP today and want a complete, easy-to-understand breakdown, this article will help you make an informed decision.
Gaudium IVF IPO GMP Today — Latest Trend
The Gaudium IVF IPO GMP (Grey Market Premium) reflects the unofficial premium at which shares are trading before listing. GMP changes daily based on demand, market sentiment, and subscription momentum.
Investors track Gaudium IVF IPO GMP to estimate possible listing gains. However, GMP is not official and should not be the only factor for investment decisions. It is best used along with fundamentals and IPO subscription status.
Market experts suggest watching:
- Daily GMP movement
- Institutional interest
- Overall IPO subscription status
- Sector outlook
Gaudium IVF IPO Date & Timeline
One of the most searched terms right now is Gaudium IVF IPO date. Here are the confirmed schedule details:
- IPO Open Date: 20 February 2026
- IPO Close Date: 24 February 2026
- Allotment Date: 25 February 2026
- Listing Date: 27 February 2026
The Gaudium IVF IPO date window is short, so investors planning to apply should complete Demat and UPI mandate steps early.
Gaudium IVF IPO Price Band & Issue Details
The Gaudium IVF IPO price band is set in an affordable mid-range, making it accessible for retail investors.
IPO Key Details:
- Total Issue Size: ₹165 Cr
- Face Value: ₹5 per share
- Gaudium IVF IPO price band: ₹75 to ₹79
- Lot Size: 189 shares
- Issue Type: Book Building IPO
- Sale Type: Fresh Capital + OFS
- Listing At: BSE and NSE
At the upper Gaudium IVF IPO price band of ₹79, the minimum investment for one lot comes to ₹14,931.
Gaudium IVF IPO Review — Should You Consider It?
A balanced Gaudium IVF IPO review should look at both growth potential and risks.
Business Strengths:
- Operates in the growing IVF & fertility segment
- Rising demand for assisted reproductive services
- Healthcare sector defensive in nature
- Expansion-focused capital usage
Risk Factors:
- Specialized medical segment competition
- Regulatory and compliance requirements
- Margin pressure risk in healthcare services
From an early Gaudium IVF IPO review perspective, the sector outlook is positive, but investors should check financials, expansion plans, and debt levels before applying.
Gaudium IVF IPO Subscription Status — What to Watch
The Gaudium IVF IPO subscription status is a key indicator of demand across investor categories:
Watch these segments:
- QIB (Qualified Institutional Buyers)
- NII (High Net-worth Investors)
- Retail Investors
A strong Gaudium IVF IPO subscription status in QIB and NII categories often signals better listing sentiment. If retail and institutional portions are heavily oversubscribed, GMP and listing expectations may improve.
Investors should track live Gaudium IVF IPO subscription status daily during the bidding period.
Gaudium IVF IPO Allotment Date & Process
The confirmed Gaudium IVF IPO allotment date is:
Allotment Finalization: 25 February 2026
After the Gaudium IVF IPO allotment date, investors can check status via:
- Registrar website
- Broker platform
- Demat account portal
Refunds (if not allotted) and share credits usually happen within 1–2 working days after the Gaudium IVF IPO allotment date.
How to Apply for Gaudium IVF IPO
You can apply through:
- Net banking ASBA
- Broker IPO platform
- UPI-based IPO application
- Demat account IPO section
Before applying, review:
- Gaudium IVF IPO GMP trend
- Gaudium IVF IPO review
- Gaudium IVF IPO subscription status
- Risk appetite and portfolio allocation
Final Thoughts on Gaudium IVF IPO GMP
The Gaudium IVF IPO GMP trend, combined with healthcare sector growth and investor interest, makes this IPO worth tracking. However, GMP alone should not drive decisions. Use a combination of fundamentals, valuation, and subscription data.
For long-term investors, business quality matters more than short-term listing gains.
About 4R Investments
4R Investments Private Limited
Stock Market & IPO Advisory Support
📞 Phone: +91 6300169336
📧 Email: contact@4rinvestments.in
📍 Address: 3-1-309/310, Tara Kaushalya Nivas, Nimboliadda, Kachiguda, Hyderabad – 500027
🌐 Website: https://4rinvestments.in/
We help investors with Demat account opening, IPO applications, mutual funds, SIPs, and equity investments.
Disclaimer
This article is for educational purposes only and not investment advice. IPO investments are subject to market risks. GMP data is unofficial and can change quickly. Investors should read the RHP and consult a financial advisor before investing. 4R Investments is not responsible for any gains or losses arising from IPO investments.